Prevalence and Major Risk Factors for Atrial Fibrillation


Atrial fibrillation prevalence, risk factors for atrial fibrillation.

How to Cite

D.M. Akpanova, A.T. Mussagaliyeva, S.F. Berkinbayev, & D.A. Ospanova. (2019). Prevalence and Major Risk Factors for Atrial Fibrillation. Journal of Pharmacy and Nutrition Sciences, 9(2), 95–100.


This research paper studies prevalence and major risk factors for atrial fibrillation. This problem is very important and significant nowadays in the medicine. People are suffering a lot and is considered one of the major health problems.
Atrial fibrillation (AF) is a heart rhythm disorder that increases the risk of stroke, disability, and mortality. The prevalence of AF in the adult population is on average 0.4–2%. According to the Global Burden of Disease (GBD) Study, about 33.5 million people in the world suffer from AF. The aim of our study was to study the prevalence of AF among the adult population of Almaty and Almaty region and the risk factors for the development of AF. Of the 1,575 respondents, 52 were found to have AF, which was 3.3%. The main risk factors for the development of AF / TP were age, diseases of the cardiovascular system, type 2 diabetes mellitus and overweight.


Zoni-Berisso M, Lercani F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical Epidemiology 2014; 6: 213-220.

Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide Epideemiology atrial fibrillation: Global Burden of Disease 2010 study. Circulation 2014; 129(8): 837-847.

Kennel WB, Benjamin EJ. Current Perceptions of Epidemiology of Atrial Fibrillation. Cardiol Clin 2009; 27(1): 13-vii.

Lip GYH, Golding DJ, et al. A survie of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation project. British Journal of General Practice 1997; 47: 285-289.

Ying L, Feng WY, Ping CK, et al. Prevalence of atrial fibrillation in China and its risk factors. Biomed Environ Sci 2013; 26 (9): 709-716.

Kai X, Xu L. Atrial fibrillation in China. Chin Med J 2013; 236(22).

Ryder KM, Benjamin EJ. Epidemiology and significance of atrial fibrillation. Am J Cardiol 1999; 84: 131R-8R.

Jeong JH. Prevalence of risk factors for atrial fibrillation in adults older than 40 years. J Korean Med Sci 2005; 20: 26-30.

Ohsawa M, Okayama, et al. It can be noted that the number of persons with atrial fibrillation in Japan has been an increase in the number of persons with a cardinal index of cardiovascular disease in 1980, 1990, 2000; 15: 194-6.

Cubillos L, Haddad A, et al. Burden of Disease from atrial fibrillation in adults from seven countries in Latin America. International Journal of General Medicine 2014; 7: 441-448.

Chamberlain AM, Agarwal SK, Folsom AR, et al. A Biracial Prospective Cohort (from the atherosclerosis risk study in communities (ARIC) study. Am J Cardiol 2011; 107(1): 85-91.

Koopman JJE, van Bogedom D, Westerndorp RGJ, Jukema W. Scarcity of atrial fibrillation in a traditional African population: a community-based study. BMC Cardiovascular Disorders 2014; 14: 87.

Levy S, Fibrillation A. The Elderly, Causes And Associated Conditions. Anatol J Cardio 2002; 2(1): 55-60.

Calvo N, Ramos P, Montserrat S, et al. Atrial fibrillation: a prospective case-control study. Europace 2016; 18: 57-63.

Murphy NF, Simpsom CR, et al. A national survie of the prevalence, incidence, primary care burden and atrial fibrillation in Scotland. Heart 2007; 93: 606-612.

Ertas F, Eren NK, Kaya H, et al. The Atrial Fibrillation in Turkey: Epidemiologic Registry. Cardiology Journal 2013; 20(4): 447-452.

Nystrom PK, Carlsson AC, Leander K, et al. Obesity, metabolic syndrome and risk of atrial fibrillation: a Swedish prospective cohort study. PLOS One.

Grundvold I, Bodegard J, Nilsson PM, et al. Body pain and newly diagnosed type 2 diabetes; an observational study. Cardiovascular Diabetology 2015; 14: 5.

Alonso A, Roetker NS, Magnani JW, et al. Blood Lipids and The Framingham Heart Study. J Am Heart Assoc 2014; 3e001211.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2019 D.M. Akpanova , A.T. Mussagaliyeva , S.F. Berkinbayev , D.A. Ospanova